Reports Q3 revenue $254.1M, consensus $253.14M. "Our third quarter sales grew 12.6% on a constant currency basis, as we continue to make market share gains by providing industry leading innovative solutions in spine care," commented Dan Scavilla, President and CEO. "Our U.S. Spine business grew an impressive 9.0%, which is evidence of our ability to hold the share gains we’ve made in the past several years, while also continuing to take new share across the U.S. market. International Spine sales increased by 11.1% on an as-reported basis, and 24.8% on a constant currency basis as we continue to increase our brand recognition on the global healthcare stage. Enabling Technologies grew 19.0% to $24.1M, driven by continued robotic system demand and new interest in our Excelsius3D imaging system. Globus Medical remains well positioned to continue providing innovative procedural solutions to help patients with musculoskeletal disorders."
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on GMED:
- Globus Medical Schedules Third Quarter Earnings Release and Conference Call
- Street Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
- Barclays starts medical devices with Positive view, Boston Scientific top pick
- Globus Medical initiated with an Overweight at Barclays
- Globus Medical initiated with a Buy at Jefferies
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue